Stanford scientists have found a cell that creates the two different compartments in the mouse lung. They hope their discovery could lead to better therapies for people with lung disease.
A researcher at the School of Medicine and his colleagues have succeeded in isolating mouse lung stem cells, growing them in large volumes and incorporating them into injured lung tissue in mice.
The work raises hopes for regenerative therapies that could heal currently intractable lung diseases.
A study describing the research was published online Nov. 6 in Nature Methods. Kyle Loh, PhD, an investigator at the Stanford Institute for Stem Cell Biology and Regenerative Medicine, and Bing Lim, MD, PhD, an investigator at the Genome Institute of Singapore, share senior authorship. The lead author is Massimo Nichane, PhD, currently a research scientist at the Stanford stem cell institute.
The lungs are among the most vital organs of the body. In conjunction with the cardiovascular system, they allow air to travel to every cell and get rid of the waste products of respiration, such as carbon dioxide. For many people with end-stage lung diseases, the only option is lung transplantation.
“Scientists have previously had little success in putting new lung cells into damaged lung to regenerate healthy tissue,” Loh said. “We decided to see if we could do that in an animal model.”
The researchers started by working to improve on current knowledge of lung stem cells. The lung is divided into two compartments, Loh said: the airway, which allows for passage of air in and out of the lung; and the alveoli, where gases pass in and out of the blood. Other researchers had previously isolated one stem cell for the airway and another stem cell for the alveoli. Loh and his colleagues searched for and found a single lung stem cell that could create cells in both the airway and the alveoli. These multipotent lung stem cells were typified by their display of a protein marker called Sox9.
From one to 100 billion billion
Once they had isolated the stem cells, they were able to make them multiply dramatically. Each mouse lung stem cell that they start started with was able to grow into 100 billion billion lung stem cells over the course of six months. Previously, researchers had not had much success expanding any lung stem cell populations in the laboratory.
Finally, they injected the stem cells into mouse lungs that had been injured by a variety of toxins. “What we saw was that these multipotent stem cells repaired the injured tissue and were able to differentiate into the many different kinds of cells that make up the healthy lung,” said Nichane.
“Our newfound ability to grow these mouse multipotent lung stem cells in a petri dish in very large numbers, and the cells’ ability to regenerate both lung airway and alveolar tissue, constitutes a first step towards future lung regenerative therapies,” Loh said. “Future work will focus on whether analogous multipotent stem cells can be found and cultivated from humans, which may open the way to eventually replenishing damaged lung tissue in the clinic.”
The Latest on: Lung injury
Experts query case for GlaxoSmithKline's new 3-in-1 lung drug
on April 18, 2018 at 2:19 pm
LONDON (Reuters) - Two medical experts have urged caution in using a new three-in-one inhaler for chronic lung disease from GlaxoSmithKline (GSK.L), which the company hopes will help it keep its lead in respiratory medicine despite rising competition. […]
Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease
on April 18, 2018 at 1:18 pm
SSIs are designed to stimulate an innate immune response in targeted organs or tissues to reverse the chronic inflammation underlying many conditions including cancer, inflammatory bowel disease, inflammatory lung disease and arthritis. SSIs are a broad ... […]
Barbara Bush Dies of COPD a Disease that Kills Women at High Rates
on April 18, 2018 at 1:15 pm
CNN had reported that Barbara Bush had COPD. According to the American Lung Association, more than 7 million women in the U.S. live with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema. There site says that ... […]
McCabe Pub set to host crawfish boil in support of co-owner with rare lung disease
on April 18, 2018 at 8:53 am
McCabe Pub is set for its sixth annual fundraiser in support of its co-owner who has a rare lung disease. Stefanie Dean Brown was diagnosed in 2010 with Lymphangioleiomyomatosis, commonly called LAM, which can cause kidney tumors and destroy lung function. […]
What Older Adults Need to Know About Lung Cancer
on April 18, 2018 at 7:02 am
Unfortunately, symptoms of lung cancer typically don’t appear until the disease is advanced, Antonoff said. Those symptoms may include a cough that won’t go away, recurrent lung infections that don’t respond to antibiotics, chest pain, a hoarse voice ... […]
Greater Cincinnati biotech firm developing cure for disease just raised millions
on April 18, 2018 at 6:26 am
Airway Therapeutics, a Sharonville biotechnology company developing a way to prevent and treat lung disease in premature babies, has raised $11 million in Series B financing from new and existing investors. The firm is developing a protein replacement ... […]
Lung disease Barbara Bush had now afflicts more women than men in U.S.
on April 17, 2018 at 6:23 pm
Chronic obstructive pulmonary disease (COPD), one of the listed causes of Barbara Bush’s death, traditionally was considered a man’s disease, but it now kills more women in the United States than men. Women account for 58 percent of the 14.7 million ... […]
Will You Change How You Treat Lung Cancer?
on April 17, 2018 at 2:10 pm
These studies in lung cancer are clearly practice changing, demonstrating that early immune checkpoint inhibition has a role with chemotherapy in the management of these diseases. But it must be recognized that this is the beginning of a journey ... […]
A New Lung Cancer Drug Is Shaking Up Treatment: How Does It Work?
on April 17, 2018 at 2:05 pm
An MRI scan shows a malignant lung tumor (indicated by a white arrow ... In addition, the median "progression-free survival time," or the time patients went without their disease getting worse, was nearly nine months in the immunotherapy group, compared ... […]
Immune therapy scores big win against lung cancer in study
on April 16, 2018 at 8:47 am
More than 4 percent of that group developed lung inflammation and three patients died of it ... In that group, survival without worsening of disease was 43 percent after one year for those on the immunotherapy drugs versus 13 percent of those on chemo. […]
via Google News and Bing News